BioSpecifics Technologies Corp. announced pursuant to the terms of the Merger Agreement, at the Effective Time, each of the officers and directors of the Company tendered their resignation as an officer and/or director of the Company and its subsidiary, as applicable. Pursuant to the Merger Agreement, as of the Effective Time, Blaise A. Coleman and Mark Bradley became members of the board of directors of the Company, with Mr. Coleman appointed as chairman of the board of directors. Mr. Mark Bradley assumed the roles of Executive Vice President and Matthew J. Maletta assumed the roles of Executive Vice President, Chief Legal Officer and Secretary of the Company.